Skip to content

Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting

Vital Signs Patch: Early Feasibility and Usability Study - Feasibility Study for Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02518100
Acronym
VSP
Enrollment
32
Registered
2015-08-07
Start date
2015-09-22
Completion date
2017-04-10
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Automated Measurement of Vital Signs

Brief summary

This feasibility study evaluates the use of the Vital Signs Patch (VSP) System to take and monitor specified vital signs. It will be used in parallel with the normal equipment the study site uses to take and monitor vital signs.

Detailed description

To assess the feasibility and usability of the total Vital Signs Patch (VSP) System in an actual hospital environment on in-patients by monitoring specified vital signs. The VSP System will be assessed for incorporation into the study site's Information Technology infrastructure. The VSP measurements will be compared with the predetermined expected results of the established vital signs equipment normally used by the facility based upon clinician protocols. The VSP System can take and monitor patient vital signs in a more reliable and consistent manner by removing the human variability that occurs when clinicians manually take a patient's vital signs. The VSP has been designed to automatically take and monitor the following vital signs: * Arterial blood oxygen Saturation (SpO2) * ECG (up to 3 - Lead) * Heart Rate (Part of ECG) * Surface Temperature * Respiration

Interventions

DEVICEVital Signs Patch (VSP) System 3-Lead (NEHB) Configuration

Vital signs will be taken using the Vital Signs Patch (VSP) System 3-Lead (NEHB) Configuration on each study participant in each Arm of this study for comparison against the same vital signs taken with traditional methods used by the facility.

DEVICEVital Signs Patch (VSP) System 1-Lead (PAL) Configuration

Vital signs will be taken using the Vital Signs Patch (VSP) System 1-Lead (PAL) Configuration on each study participant in each Arm of this study for comparison against the same vital signs taken with traditional methods used by the facility.

Sponsors

LifeWatch Services, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult male and female hospital in-patients * Vital signs considered 'stable' by clinical caregivers

Exclusion criteria

* Pediatric patients * Female patients who are pregnant * Patients with internal or external defibrillators * Patients who have undergone surgery and still have a fresh incision on the chest * Patients with skin damage on the chest such as burns, irritation, infections, wounds, etc. * Patients who are in the Critical Care Unit (CCU) * Patients who otherwise satisfy any of the contraindications associated with the VSP system.

Design outcomes

Primary

MeasureTime frameDescription
Composite Outcome Measure - Successful Vital Signs AcquisitionUp to Four DaysSuccessful acquisition of Temperature, Heart Rate, ECG, Respiration, SpO2 daily for the inpatient stay of the subject up to four days. Success is achieved if all vital signs are obtained on a study participant. It is a composite result.

Secondary

MeasureTime frameDescription
AdhesionUp to Four DaysSuccessful performance of the adhesive of the vital signs patch during use on subjects. Adhesion will be measured as either positive or negative for each subject.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026